PAPER Yakovleva O, Janiak A, McKenzie C, McShane L, Brown P, Cervenakova L

Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice.

Transfusion. 2004 Dec;44(12):1700-5. PubMed.

PAPER Fagge T, Barclay GR, Macgregor I, Head M, Ironside J, Turner M

Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry.

Transfusion. 2005 Apr;45(4):504-13. PubMed.

PAPER Sowemimo-Coker S, Kascsak R, Kim A, Andrade F, Pesci S, Meeker C, Carp R, Brown P

Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.

Transfusion. 2005 Dec;45(12):1839-44. PubMed.

PAPER Guntz P, Walter C, Schosseler P, Morel P, Coste J, Cazenave JP

Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.

Transfusion. 2010 May;50(5):989-95. PubMed.

PAPER Sowemimo-Coker SO, Demczyk CA, Andrade F, Baker CA

Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay.

Transfusion. 2010 May;50(5):980-8. PubMed.

PAPER Tattum MH, Jones S, Pal S, Collinge J, Jackson GS

Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification.

Transfusion. 2010 May;50(5):996-1002. PubMed.

PAPER Tattum MH, Jones S, Pal S, Khalili-Shirazi A, Collinge J, Jackson GS

A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K.

Transfusion. 2010 Dec;50(12):2619-27. PubMed.

PAPER Holmqvist J, Wikman A, Pedersen OB, Nielsen KR, Rostgaard K, Hjalgrim H, Edgren G

No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.

Transfusion. 2020 Apr;60(4):694-697. Epub 2020 Mar 18 PubMed.

PAPER Saá P

Is sporadic Creutzfeldt-Jakob disease transfusion-transmissible?

Transfusion. 2020 Apr;60(4):655-658. PubMed.

PAPER Crowder LA, Dodd RY, Schonberger LB

Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.

Transfusion. 2024 Jun;64(6):980-985. Epub 2024 Apr 22 PubMed.

PAPER Vilotte JL, Laude H

Transgenesis applied to transmissible spongiform encephalopathies.

Transgenic Res. 2002 Dec;11(6):547-64. PubMed.

PAPER Li B, Ryder J, Su Y, Moore SA, Liu F, Solenberg P, Brune K, Fox N, Ni B, Liu R, Zhou Y

Overexpression of GSK3betaS9A resulted in tau hyperphosphorylation and morphology reminiscent of pretangle-like neurons in the brain of PDGSK3beta transgenic mice.

Transgenic Res. 2004 Aug;13(4):385-96. PubMed.

PAPER Olson LE, Tien J, South S, Reeves RH

Long-range chromosomal engineering is more efficient in vitro than in vivo.

Transgenic Res. 2005 Jun;14(3):325-32. PubMed.

PAPER Martin C, Plat M, Nerriére-Daguin V, Coulon F, Uzbekova S, Venturi E, Condé F, Hermel JM, Hantraye P, Tesson L, Anegon I, Melchior B, Peschanski M, Le Mauff B, Boeffard F, Sergent-Tanguy S, Neveu I, Naveilhan P, Soulillou JP, Terqui M, Brachet P, Vanhove B

Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation.

Transgenic Res. 2005 Aug;14(4):373-84. PubMed.

PAPER Guillemot F, Cerutti I, Auffray C, Devignes MD

A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Transgenic Res. 2007 Apr;16(2):223-37. PubMed.